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Abstract – Premature centromere division (PCD) can be viewed as a manifestation of chromosome instability. In order 
to evaluate the ability of Paclitaxel (Ptx) and Cycloheximide (Cy) to induce PCD we used a cytokinesis block 
micronucleus assay (CBMN), fluorescent in situ hybridization (FISH), and the chromosome aberration (CA) assay in 
human peripheral blood lymphocytes. Results showed that Ptx can induce PCD alone or in combination with Cy. These 
findings call us to pay more attention to PCD as a parameter of genotoxicity in the pre-clinical research of mono- 
and/or combinational therapies for cancer treatment.  
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INTRODUCTION 
In a four dimensional cascade of cyclin regulated cell 
cycle kinetics, chromosomes possess an essential role in 
maintaining the stability of the fluctuating genome. 
Numerous data show that the spatial organization of 
chromosomes is accompanied by the temporal regu-
lation of replication (Amiel et al., 1998; Litmanovitch et 
al., 1998; Reish et al., 2002) and the separation and 
segregation of these processes in dividing cells (Garcia-
Orad et al., 2000; Mailhes et al., 2003; 2008). 
Centromere separation is a sequential/temporal process 
in which certain chromosomes tend to separate first. In 
humans the first chromosome to separate is chromo-
some 18. In an ordered sequence, chromosomes 17, 2, 
10, and 12 follow the separation of chromosome 18 
(Vig et al., 1989; Spremo-Potparevic and Bajic, 2000; 
Bajic et al., 2007).  
This sequence of chromosome separation can 
be deregulated in ageing cells (Fitzgerald et al., 
1986; Zivkovic et al., 2006), Alzheimer’s disease 
(Miglore et al., 1997; Spremo-Potparevic et al., 
2004; 2008; Zivkovic et al., 2006; Bajic et al., 2008) 
various tumors and chromosome instability syn-
dromes (Choo, 1997). Recent investigations have 
found that premature centromere division (PCD) 
yields are significantly higher in populations ex-
posed to mixed chemicals, pesticides, crude oils and 
cytostatic drugs (Mailhes et al., 1999; Major et al., 
1999; Vig and Hallet, 2000; Rodriguez et al., 2001; 
Bajic et al., 2007, 2009). Centromere instability has 
been recognized as a hallmark of human cancer 
caused by continuous mis-segregation during 
mitosis in which errors of centromere separation, 
particularly PCD. is seen to have a fundamental role 
(Vig and Sternes, 1991; Vig et al., 1993). PCD is 
today a well-recognized phenomenon associated 
with aneuploidy (Miglore et al., 1997; Mailhes et al., 
1998; 2003, 2008; Vig and Hallet, 2000; Steuerwald 
et al., 2005; Tomonaga et al., 2005; Zivkovic et al., 
2006).  
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The use of chemotherapy has become more 
extensive in recent years and has added to the 
success of treatments, but it has also permitted the 
assessment of survivors for the development of 
second malignant tumors (Pedersen-Bjergaard and 
Philip, 1988; Leone et al., 1999; Green et al., 2000).  
Paclitaxel (Ptx) alone or in combination with 
other antitumor agents is widely used in a variety of 
tumor treatments, however, Ptx can induce 
chromosome damage and aneuploidy, thereby 
enhancing the possibility of survival of damaged 
cells (Bouchet et al., 2007). A number of studies 
have addressed the ability of Ptx to induce 
aneuploidy in vivo (Tinwell and Ashby, 1994; 
Mailhes et al., 1999) and in vitro (Jagetia and Adiga, 
1995; Bouchet et al., 2007).  
Tinwell and Ashby (1994) presented that Taxol 
(Taxol is the generic name for paclitaxel) induced 
an increase in the frequency of micronuclei (MN) 
in the mouse bone-marrow micronucleus assay. 
This data may indicate a carcinogenic potential of 
taxol for humans. Taxol showed a positive Comet 
test (single-strand breaks) on proliferating 
lymphocytes at doses of 5 and 7.5 nM but not in 
resting cells, even at 5 to 15 μM (Digue et al., 1999). 
Also, Taxol may suppress centromere dynamics in 
osteosarcoma cells (Kelling et al., 2003).  
Cycloheximide (Cy) does not exhibit a 
genotoxic potential in either the Comet assay 
(Henderson et al., 1998) or in the micronucleus 
assay (Bajic et al., 2007) in vitro, however it can 
induce centromere instability (Bajic et al., 2007), or 
premature centromere division. In this study we 
addressed the potential of Ptx to induce PCD, alone 
and with Cycloheximide, a known protein 
inhibitor, as well as the possible relationship of 
induced PCD to Ptx clastogenicity/genotoxicity. 
Fluorescent in situ hybridization (FISH) was 
used in correlation with the cytokinesis block 
micronucleus assay (CBMN). CBMN is a 
comprehensive system for measuring DNA 
damage, cytostasis and cytotoxicity and is used as a 
reliable endpoint in the evaluation of the genotoxic 
risk of various cytotoxic agents and xenobiotics 
(Bonassi et al., 2007; Fenech, 2007; Djelic et al., 
2008). Detection of chromosome 18 was chosen 
because it is the first chromosome to separate, and 
thus segregate in the metaphase anaphase transition 
(Rodriguez et al., 2001; Steuerwald et al., 2005). The 
most prominent finding was that Cy induced a 
change in the pattern of PCD occurrence by Ptx 
which correlated with a significantly higher NDI 
suggesting the survival of cells that clearly show 
centromere instability. FISH for the α-centromeric 
probe of chromosome 18 detected dot-like signals 
in mononucleated, bi-nuclear and multilobulated 
nuclei induced by Ptx which clearly expresses PCD. 
Here we argue that increased levels of chromo-
somes affected by PCD induced by Ptx alone or in 
combination may lead to increased genome 
instability in normal peripheral blood lymphocytes.  
MATERIAL AND METHODS 
Material 
For all experiments the material used was obtained 
from the human peripheral blood of ten healthy male 
subjects, 25-35 years of age who were non-smokers. 
Cycloheximide (CAS No. 66-81-9) and Paclitaxel 
(Taxol®) (CAS No. 33069-62-4), were purchased 
from Sigma–Aldrich Inc., St. Louis, MO, USA. 
Protocol for Cy combination with Ptx 
Peripheral blood lymphocytes were exposed to Cy 
in a dose of 10 μg/ml for an 18 h incubation time 
without adding phytohemagglutinin (PHA) (G0-
phase). After 18 h of incubation with Cy, the Cy 
was rinsed out, phytohemagglutinin was added and 
after 48 h increasing doses of Ptx were added for 24 
h. The same protocol was used for both the 
chromosome aberration (CA) assay and CBMN.  
The CBMN 
CBMN in vitro was done as described by Fenech 
(2000). Peripheral blood samples from 10 male 
subjects were collected in previously heparinized test 
tubes. Cells from lymphocyte rich plasma were 
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cultivated in a density of 5 × 105 cells/ml in RPMI 
1640 medium supplemented with 15% fetal calf serum 
(FCS) and a standard solution of antibiotics (penicillin 
and streptomycin, Galenika, Belgrade). Three groups 
were established. One of them was the control group 
or phosphate buffered saline (PBS)-treated group. The 
other two were the experimental group with cells 
exposed to Ptx alone and the experimental group with 
a combination of Cy and Ptx.  
All groups were incubated for 18 h before 
adding PHA. After incubation the cells were rinsed 
and the remaining Cy was washed off with RPMI 
1640. The lymphocytes of all the groups were 
stimulated by adding PHA (Murex Diagnostics Ltd, 
Dartford, England) at a final concentration of 5 
μg/ml. 48 h after PHA stimulation, Ptx was 
supplemented to the cultures in a dose of 10, 50 and 
200 nM. 44 h after PHA stimulation Cytochalasin B 
was added at a concentration of 6 μg/ml. After 24 h 
the cells were centrifuged for 10 min at 2000 rpm, 
treated with a hypotonic solution (0.56% KCl plus 
0.9% NaCl mixed in equal volumes) and then fixed 
with the conventional 3:1 methanol:acetic acid 
fixative for 10 min. Cell suspensions after the last 
fixation were dropped onto clean grease-free slides. 
After air drying (24 h) the cells were stained with 
2% Giemsa (Merck, Darmstadt, Germany) for 3 
min. The blood samples were coded with an 
identification number and the slides were scored 
blindly. For MN analysis, at least 1000 binucleated 
(BN) cells were analyzed per culture and MN was 
accepted according to the criteria of Fenech (2000). 
The ability of the cells to proliferate in vitro was 
evaluated by counting the number of cells with one, 
two and four MN on the same slide using the 
nuclear division index (NDI), calculated according 
to the formula: NDI = (MI+2MII+3MIII+4MIV) / N, 
where MI to MIV represent the number of cells with 
one to four nuclei, respectively, and N is the 
number of cells scored. 
The chromosome aberrations (CA) assay for the 
analysis of PCD 
For the CA/PCD analysis, the cultures were 
processed in the same way as in the CBMN except 
that the hypotonic treatment was performed with 
pre-warmed 0.075 M KCl for 15 min at 37°C. 
During the last two hours of incubation colcemid 
(Ciba, Basel. Switzerland) was added to the medium 
in a concentration of 0.05 μg/ml. The air dried 
slides were stained with 10% Giemsa at pH=6.8. 
Metaphase chromosome analysis for the detection 
of PCD was performed according to the 
conventional technique by Evans and O'Riordan 
(1975). Metaphase nuclei were screened for the 
presence of altered centromere dynamics, i.e. PCD. 
PCD was evaluated in 100 metaphase chromosomes 
based on the distribution pattern, i.e. presence of 
PCD on less than two chromosomes, more than 
two and on all chromosomes per one metaphase.  
Fluorescent in situ hybridization (FISH) for 
chromosome 18 
Probe preparation 
Chromosomes were prepared in the same way as in 
the experiment for the CBMN and CA assay. The 
pL 1.84a repetitive DNA probe (Oncor) for the 
centromeric region of chromosome 18 was used. 
The probe was labeled with biotin-16 dUTP 
nucleoside-triphosphate in nick-translation reac-
tion. For each slide approximately 50 ng of probe 
was mixed in 16 ml of hybridization buffer, 
consisting of 50% formamide, 10% dextran-sulfate, 
1% SDS, 1 x Denhardt’s solution, and 2 x SSC (1 x 
SSC:0.15 M NaCl and 0.15 M sodium citrate, pH 
7.0).  
Hybridization and detection  
Hybridization and detection were performed as 
previously described (Wilkinson, 1995). The 
biotinylated probe was detected with avidin-DCS 
conjugated to yellow-green flurophore FITC 
(fluorescein isothiocyanate; exc.max. 523 nm) (4 
mg/ml) and biotinylated anti-avidin DCS (4 mg/ml, 
Vector Laboratories). The signals were amplified 
using three layers of avidin-FITC. The slides were 
mounted in 0.4 mg/ ml 40-6-diamidino-2-
phenylindole (DAPI) and propidium iodide 
counterstain in vectashield antifade buffer. The 
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slides were examined by using an Olympus RFL 
BH2 fluorescence microscope with an appropriate 
filter combination for detecting fluorescein, and 
propidium iodide (0-515 nm) was used for signal 
detection and evaluation. The bipartite centromere 
signal of chromosome 18 in interphase nuclei was 
evaluated as PCD, 18+ while the one dot-like signal 
was evaluated as PCD, 18-. The slides were 
photographed using Fuji 100 color film. 
Statistical analysis 
For statistical analysis we used the Mann-Whitney 
U-rank test performed by Windows compatible 
program Statistica 5.0 for establishing the frequency 
of MN and the χ2-test for estimating the NDI. A p-
value of ≤ 0.05 was considered as indicative of 
statistical significance for all tests used.  
RESULTS 
Our results show that Ptx can induce PCD in 
human peripheral blood lymphocytes alone or in 
combination with Cy. For PCD analysis we used the 
CA assay. Our results show that when compared to 
the control group, Ptx alone and in combination 
with Cy can induce a significant (p < 0.001)  
Table 1. Comparative estimation of PCD in control and experimental groups treated with Cy and Ptx 
No of analyzed 
mitosis 
PCD induced on 
less than two 
chromosomes 
PCD induced on 
more than two 
chromosomes 
PCD induced on all 
chromosomes 
The overall number of 
mitosis with PCD 
Concentration 
mean±S
D 
(%) mean±S
D 
(%) mean±S
D 
(%) mean±S
D 
(%) mean±S
D 
(%) 
Negative control 
(K) 
121 ± 
9.7 
100 / / / / 2.0 ± 1.4 1.6 2.0 ± 1.4 1.6 
10 nM Ptx (A) 123 ± 
4.5 
100 4.9 ± 1.9 4.0 65.3 ± 3.0 53.8 9.0 ± 1.2 7.3 79.2 ± 4.0 64.3 
50 nM Ptx (B) 115 ± 
9.5 
100 1.3 ± 0.7 1.1 68.5 ± 2.3 59.5 
15.0 ± 
2.3 
13.0 84.8 ± 3.0 73.6 
200 nM Ptx (C) 98 ± 
10.3 
100 0.2 ± 0.4 0.0 35.4 ± 2.0 36.0 
40.5 ± 
3.7 
41.3 75.9 ± 4.0 77.5 
Cy/10 nM Ptx (D) 119 ± 
7.7 
100 4.0 ± 1.3 3.3 71.5 ± 3.2 60.0 
16.9 ± 
2.7 
14.2 88.8 ± 4.0 75.0 
Cy/50 nM Ptx (E) 122 ± 
4.3 
100 0.9 ± 0.5 0.7 68.5 ± 2.7 56.1 
40.6 ± 
2.6 
33.0 110.0 ± 
3.0 
90.0 
Cy/200 nM Ptx (F) 107±8.5 100 / / 31.3±2.8 29.2 61.5±2.5 57.4 91.8±5.0 87.0 
 
K:A=86.7**; K:B=151***; K:C=83**; K:D=96***; K:E=200***; K:F=70***; K:CX=29*** 
A:B=5***; B:C=7***; A:C=2,52*; D:E=10***; D:F=2.04 (NS)    
E:F=5.4***; A:D=6.6***; B:E=25***; C:F=10*** 
df=38; t0,05=2,04; t0,01=2,55; t0,001=3,64  
NS=non-significant, *p<0.05, **p<0.01, ***p<0.001 (Student’s t-test for statistical analysis of the overall number of 
mitosis with PCD)
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 increase in the overall percentages of PCD in all 
given doses (Table 1). When comparing 
experimental groups, Ptx alone and in a 
combination of Cy and Ptx, an interesting pattern is 
revealed, i.e. there is a significant (p < 0.001) 
increase in the overall percentages of PCD and a 
shift in the distribution of PCD occurrence. In the 
Ptx alone group, at a dose of 50 nM, the percentage 
of PCD occurring on all chromosomes was shifted 
from 13% to 33% in the group that was previously 
treated with Cy. This shift is seen in all respective 
doses with Ptx (Table 1, Figure 1). Here we see that 
incubation of cells with Cy in combination with Ptx 
induces a chromosome imbalance by expressing an 
increasing level of PCD with increasing doses of 
Ptx.  
The same microscope slides used for observing 
micronuclei were also examined for cytotoxic and 
cell-cycle delay effects. The cytostatic effects of Ptx 
alone or in combination with Cy in the CBMN test 
were measured via the proportion of mono-, bi- 
and multinucleated (three and four nucleated) cells, 
i.e. the nuclear division index. The NDI shows the 
proliferative capability of peripheral blood lympho-
cytes. Comparing the doses in the experimental 
group with Ptx alone and the combinational group 
with increasing doses of Ptx (10, 50 and 200 nM), 
an increase of the NDI (1.112, 1.078 and 1.065) was 
observed, showing an increase in the possible 
cytoprotective effect of Cy (Table 2). By using the 
χ2-test we can see that the proliferative index shows 
a significant (p < 0.01) difference between the 
experimental group with Cy (F) and the 
experimental group with Ptx alone in a dose of 
200nM (C) indicating that a cytoprotective effect 
may be at hand (Table 2). Of interest is that the 
proportion of bi-nuclear cells in the experimental 
groups are decreased in all experimental doses 
compared to the control group (Table 2). This 
difference is highly statistically significant (p < 
0.01). Comparing the NDI and % of BNC we can 
conclude that cells that survive the first division (% 
BNC) may follow an increase in second divisions 
seen as an increase in the NDI in the combination 
experimental group (Table 2).  
 
Figure 1. Metaphase nuclei showing increased occurrence of
premature centromere division (PCD) and chromosome
condensation induced by increasing doses of Paclitaxel (Ptx).
Paclitaxel (Ptx) dose 10nM (a); Ptx dose 50nM (b); Ptx dose
200nM (c). From Fig. 1a to Fig. 1c we see increased instability
of chromosomes. With increasing doses of Ptx, premature
centromere division has shifted from a few chromosome that
are affected (a) to all chromosomes (b & c). Also, we can see
that chromosome condensation is more profound in higher
doses. 
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Table 2 shows a significant (p < 0.001) diffe-
rence in the number of binuclear cells with 
micronuclei (MN) between the negative control 
group (5.0±3.0) and both experimental groups, 
combination of Ptx and Cy and Ptx alone in the 
following doses: 10 nM (12.5±5.0; 14.5±4.3, res-
pectively); 0.05 μM (20.3±5.3; 21.7±5.1, res-
pectively) and 200 nM Ptx (27.8±8.4; 28.8±9.2, 
respectively). These results show that all doses of 
 
Ptx, whether alone or in combination, are geno-
toxic when compared to the control group. When 
comparing both experimental groups our results 
show that there is no statistically significant 
difference between any of the used doses (Table 
2). These results show that there is no correlation 
between the increase of chromosomes affected by 
PCD and Ptx aneugenic potential alone or in 
combination with Cy (Table 2). 
Table 2. Number of MN in peripheral blood bi-nuclear lymphocytes in control and experimental groups 
No. MN in 103 BNC 
Concentration 
Avarage 
No. of 
cells 
analyzed 
% of BNC 
mean SD 
NDI 
FISH analysis 
18* + 
MN/1000cells 
Control (K) 1028 55.7 5 3.0 1.707 / 
10 nM Ptx (A) 1024 8.9 12.5 5.0 1.100** 1 
50 nM Ptx (B) 1000 5.6 20.3 5.3 1.063*** 2 
200 nM Ptx (C) 1013 4.2 27.8 8.4 1.039*** 1 
†Cy/10 nM Ptx (D) 1022 9.1 14.5 4.3 1.112*** / 
†Cy/50 nM Ptx (E) 1000 5.9 21.7 5.1 1.078*** 1NS 
†Cy/200 nM Ptx (F) 1008 4.3 28.8 9,2 1.065*** 2NS 
 
∞BNC=binucleated cells; MN=micronuclei; §nuclear division index, †cycloheximide(10μg/ml); 18*-chromosome 18 signal 
K:A, U=9; p<0.0002***  A:B, U=14; p<0.00651**  A:D, U= 37; p<0.325 (NS) 
K:B,U=000; p< 0.000157*** A:C, U=5.5; p< 0.00076*** B:E, U=42; p<0.57 (NS) 
K:C, U=000; p< 0.00015*** B:C, U=24.5; p< 0.054*  C:F, U=48; p<0.87 (NS) 
K:D, U=3.5; p< 0.0044*** D:E, U=15; p<0.0081***  K:CX, U=47; p<0.85 (NS) 
K:E, U= 1.5; p<0.0002***  D:F, U=11; p<0.0031** 
K:F, U=000; p< 0.000157*** E:F, U=27; p< 0.082* 
*statistical difference (p<0.05)  
**p<0.01, ***p<0.01, NS= non-significant (Mann-Whitney U-test for CBMN and X2 test for NDI) 
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The CBMN is readily used for FISH analysis. In 
our study we used FISH to detect if PCD occurs 
throughout the cell cycle, i.e. bi-nuclear cells that 
passed from the first division, and three nuclear and 
four nuclear that passed the second division. We 
also used the FISH of chromosome 18 to establish 
the possibility of signal detection in MN in both 
experimental groups.  
Analysis of chromosome 18 by FISH 
A small number of signals that were found in 
MN (Table 2) showed no statistical difference. Still, 
some features of the signals showing the PCD of 
chromosome 18 in bi-nuclear and multilobulated 
cells are addressed: (i) in Fig. 2 chromosome 18 is 
presented by 2 dot-like signals in every nuclei 
representing normal segregation of centromeres 
(PCD-); (ii) some nuclei are presented by 4 dot-like 
signals showing the presence of PCD of 
chromosome 18 (Fig. 3). These results indicate the 
complete segregation of chromosome 18 
centromeres in the presented bi-nuclear cell. Both 
experimental groups show the same pattern of 
events; (iii) some nuclei and multilobulated nuclei 
show rod-like signals (A) suggesting the initiation 
of PCD (Fig. 4). The occurrence of PCD and 
normal signals in multilobulated nuclei show us 
that cells, even though impaired, show activity and  
 
may have survived by abrogating the cell cycles 
checkpoint controls. 
The resultys of FISH analysis clearly revealed 
that the properties of the investigated agent alone or 
in combination can induce the PCD of 
chromosome 18 in mononucleated cells, bi-
nucleated cells and in multilobulated nuclei. 
DISCUSSION 
In cancer therapy cytotoxicity induced by the 
administered chemotherapeutic agents, whether 
 
Figure 2. A representative binucleated (A) and mononucleated
cell (B) with normal dot-like signals for chromosome 18. 
 
Figure 3. Representative multilobulated nucleus induced by a 
Paclitaxel (Ptx) dose 50nM in combination with Cycloheximide 
(Cy) and a bi-nuclear cell with dot like signals for chromosome 
18 (PCD-). 
 
Figure 4. A representative binucleated cell with premature 
centromere division (PCD) of chromosome 18. 
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alone or in combination, is a desirable consequence 
of their action. Genotoxic damage by anticancer 
agents in tumor cells leads to cell death, a favorable 
property of cytostatics (Branch et al., 2000). 
However, increased genetic alterations may have 
adverse consequences if the affected cells are not 
malignant. In fact, it has been shown that genetic 
instability, characterized by an abnormal number of 
chromosomes, is associated with secondary 
malignancies. Thus, it is necessary to evaluate the 
potential aneugenicity of chemotherapy to humans 
before its clinical use.  
A number of mechanisms have been proposed 
for aneuploidy induction (Mailhes et al., 1997) and 
the one of interest is that centromere instability has 
been correlated to increased aneuploidy from 
various xenobiotics. PCD is now generally 
recognized as a predisposition to aneuploidy 
(Fitzgerald et al., 1986; Mailhes et al., 1997, 1998, 
1999; 2008; Major et al., 1999; Vig and Hallet, 2000; 
Steuerwald et al., 2005).  
Our results showed that Ptx can induce 
centromere instability by separating centromeres 
before their time. This property can be induced by 
Ptx alone, or in combination with Cy. Moreover, 
the synergistic action of Cy and Ptx shows a change 
in the distribution pattern of PCD occurrence on 
chromosomes when compared to Ptx alone, i.e. 
PCD occurs on more than one chromosome 
showing increased chromosome instability (Fig. 1, 
Table 1). Nonetheless, Cy increased the measure of 
cell proliferation or the nuclear division index in 
the Cy and Ptx combinational experimental group 
when compared to Ptx alone. Elevated NDI but not 
the number of MN may show the survival effect of 
affected cells with PCD (Table 2) in the 
combination experimental group.  
Other research has showed that a dose of 10 
μg/ml Cy can induce cytoprotective action in 
various cell from various noxic stimuli (UV light, 
thermal exposure and toxic compounds) (Lee and 
Dewey, 1987; Lee et al., 1991; Liebmann et al., 1994; 
Lynch et al., 2008). Cy may antagonize the 
cytotoxicity of a variety of chemotherapeutic 
agents, including actinomycin, doxorubicin, 
etopsid, vincristin and Taxol (Liebmann et al., 
1994). In these studies different cell lines and 
protocols were used compared to our study. Thus 
in our study we argue that centromere instability 
which leads to PCD may be regarded as a marker of 
damaged cells which in turn show (elevated NDI 
and MI) a pseudo-cytoprotective effect.  
The NDI gives us a more accurate measure of 
cytotoxicity vs cytoprotectivity than classical MI 
from the CA assay (data not shown), i.e. both 
experimental groups, Ptx alone or in combination 
with Cy, show a high statistical difference in the 
NDI when compared to the control group. Still, 
there is a difference in NDI when comparing the 
experimental groups. These results show that cells 
with an abnormal number of chromosomes with 
PCD survive at least one cell division (see Fig. 1, 
Table 2). The severity of PCD is based upon the 
chromosomes affected (Matsuura et al., 2000). 
Infants with cells that express PCD in 70-90% of 
their chromosomes develop a phenotype with 
developmental abnormalities accompanied by 
Wilm’s tumor and consequently die at the age of 
three.  
The FISH of chromosome 18 was used to detect 
PCD in all phases of the cell cycle by combining 
with the CBMN test. Chromosome 18 is the first 
chromosome to separate and thus segregate in the 
metaphase-anaphase transition and is one of the 
chromosomes that is most seen in other 
aneusomies, miscarriages, various tumors, 
syndromes and Alzheimer's disease (Choo, 1997; 
Zivkovic et al., 2006). Premature sister chromatids 
and centromere separation is a parameter of 
instability which may lead to mitotic checkpoint 
abrogation and aneuploidy (Vig and Sternes, 1991; 
Mailhes et al., 1998; Matsuura et al., 2000; 
Rodriguez et al., 2001; Steuerwald et al., 2005; Bajic 
et al., 2008). The property of chromosome 18 to 
divide first in a sequential manner was used to 
evaluate the possibility of preferential induction of 
chromosome 18 aneuploidy in micronuclei by Ptx 
and Ptx in combination with Cy. The notion of 
preferential aneugenicity was based on the fact that 
 EFFECTS OF PACLITAXEL AND CYCLOHEXIMIDE 71 
chromosome 18 is the first chromosome to separate 
and thus segregate in the metaphase-anaphase 
transition of the cell cycle and by the work of 
Wuttke et al. (1997) who found the preferential 
occurrence of chromosome 7 aneuploidy induced 
by colchicine in MN using FISH. 
Our results showed no statistical difference in 
the detection of chromosome 18 in MN between 
the experimental groups and the control group 
(Table 2). Still, PCD has been detected in mono-, 
bi-nucleated cells and multilobulated nuclei (Figs. 3 
and 4) in cells exposed to Ptx alone or in 
combination with Cy. Our observations correspond 
to other studies that have demonstrated that Ptx 
arrested cells in mitosis and that prolonged 
exposure of cells to Ptx resulted in the development 
of multilobulated nuclei (Morse et al., 2005). The 
above results show that not only is PCD found in 
various stages of the cell cycle but it  is also 
prominent in an altered nuclear phenotype, i.e. 
multilobulated nuclei, indicating chromosome/cen-
tromere instability which may lead to mitotic 
catastrophe.  
A recent review about mitotic cell death showed 
that features of mitotic catastrophe induced by 
Taxol are not simply a representation of dying cells 
but are indicative of a switch to amitotic modes of 
cell survival that may provide additional 
mechanisms of genotoxic resistance 
(Theodoropoulos et al., 1999; Erenpreisa and 
Cragg, 2001; Morse et al., 2005). Our results are in 
agreement with the survival views even though the 
model used in our study is somewhat deficient, i.e. 
human peripheral blood lymphocytes are harvested 
after 72 h so that cells that show a survival pattern 
might go into apoptosis or some other form of cell 
death if left to proliferate for more than 72 h. Thus, 
the explanation of the possible survival of damaged 
cells observed in the experimental group with Cy 
and Ptx can be explained by the ability of Cy to 
synergistically act with Ptx in the induction of PCD, 
thereby acting on the centromere proteins that 
induce chromosome instability and possible 
alteration of the mitotic checkpoint control. Cy 
increased the number of chromosomes affected by 
PCD when subsequently exposed to Ptx. Our 
results agree to some extent with Bouchet et al. 
(2007) who showed that Ptx can induce an 
aneuploidy prone phenotype and apoptosis 
resistance in normal epithelial mammary cells. This 
induced instability may be detrimental to normal 
cells leading to secondary tumors.  
CONCLUSION 
The instability of centromeres in normal cells 
should be taken into account when evaluating the 
genotoxic risk/benefit ratio of anti-tumor agents in 
pre-clinical trials. For now these investigations can 
help us to better assess the risk of combined 
therapies and therefore contribute to a more exact 
evaluation of the current therapeutic regimes and to 
the development of new pathways for targeting 
malignancy. 
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Превремена центромерна деоба (PCD) се 
може посматрати као манифестација хромо-
зомске нестабилности. У циљу процене ефекта 
паклитаксела (Ptx) и циклохексимида (Cy) на 
индукцију PCD-a, користили смо микронуклеус 
тест (CBMN) уз флуоресцентну in situ хибри-
дизацију (FISH), као и тест хромозомских абе-
рација (CA) на хуманим лимфоцитима пери-
ферне крви. Резултати су показали да Ptx сам, 
или у комбинацији са Cy може да индукује PCD. 
Ови налази указују да треба много више пажње 
обратити на појаву PCD-a као параметра ге-
нотоксичности у преклиничким испитивањима 
моно- и/или политерапија за лечење канцера. 
 
